Form 4: Neuraxis Director Gil Aharon Boosts Stake

Neuraxis, INC Director Gil Aharon acquired 21,598 common shares as compensation for services, increasing his beneficial ownership to 307,736 shares.

Summary

• Gil Aharon, a Director of Neuraxis, INC, acquired 21,598 common shares.
• The transaction occurred on January 22, 2026.
• The shares were issued as compensation for services as an independent director.
• The acquisition price per share was $4.63.
• Following this transaction, Gil Aharon beneficially owns a total of 307,736 common shares.
• This total includes 286,138 shares owned by Rosalind Master Fund L.P. and the newly acquired 21,598 shares directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates a director's increased equity stake, aligning their interests with shareholders, even if it's compensation-driven.

Positives

• Director Gil Aharon increased his direct ownership in Neuraxis, INC by 21,598 common shares, demonstrating continued alignment with shareholder interests.
• The issuance of shares as compensation for independent director services is a common practice that aligns management incentives with company performance.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider buying, particularly by directors, can often be interpreted by the market as a positive signal, indicating confidence in the company's future prospects. While this specific transaction is compensation-related, it still increases the director's personal stake in Neuraxis, INC.

Comparison to Industry Standards

• Issuing equity as compensation for independent directors is a standard practice across various industries, including biotechnology and healthcare, where Neuraxis, INC likely operates.
• Companies like Moderna (MRNA) or BioNTech (BNTX) also utilize equity compensation to align director interests with long-term shareholder value.
• The specific value of $4.63 per share for compensation is within typical ranges for such transactions, depending on the company's market capitalization and the director's responsibilities.

Related Party Transactions

• The issuance of 21,598 common shares to Director Gil Aharon as compensation for services constitutes a related party transaction, which is a standard practice for independent director remuneration.

Stakeholder Impact

• Shareholders: The transaction slightly increases the director's alignment with shareholder interests. There is a minor dilutive effect from the issuance of new shares, but this is typical for equity compensation.
• Management: The director's increased stake may foster greater commitment to the company's strategic goals.

Key Dates

Keywords

Neuraxis, NRXS, Gil Aharon, Form 4, insider transaction, director compensation, common shares, beneficial ownership, equity acquisition